Researchers conducted a systematic review on herbal medicines as adjuvant therapy for COVID-19, analyzing clinical trials from various countries. Results focused on Length of Stay, Negative Conversion Time, and Negative Conversion Rate. Important for potential alternative treatment options.
Researchers investigated medicinal plants as potential therapies for COVID-19, using quantum sensing methods to analyze their interactions with COVID protein. Results suggest these plants could be effective against COVID-19 symptoms, aiding drug design efforts.
Endophytic fungus from fruit peels produces compounds with potential antibacterial and antiviral properties. Strong activity against MRSA and biofilm formation, weak against Gram-negative bacteria. Promising antiviral activity against HCoV 229E. Molecular docking shows potential as drug targets.
Guduchi Ghana Vati showed potential as a preventive remedy for COVID-19 and other infections in a healthy population, with lower severity and hospitalization requirements in those taking it. It is safe and effective for preventing infections and boosting immunity.
Hazelnut peptides WWNLN and WAVLK inhibit SARS-CoV-2 protease M, boosting immune cell function and cytokine release. WWNLN shows stronger inhibition and better pharmacokinetic properties. Important for developing antiviral treatments.
Researchers used pumpkin seed meal to create ACE inhibitory and ACE2 upregulating peptides. Two identified peptides showed significant ACE inhibition activity and were stable during digestion. These peptides have potential as antihypertensive agents.
NLCs loaded with essential oils inhibit SARS-CoV-2, with promising results exceeding 2-log reduction in virion count. Innovative strategy for combating SARS-CoV-2.
Study found lower CLU concentrations, higher levels of specific glycan reactivities in severe COVID-19 patients compared to convalescents and healthy individuals. These glycomarkers could help differentiate disease severity.